Scott Requadt
Director/Board Member at ESSA PHARMA INC.
Net worth: 2 M $ as of 2024-04-29
Profile
Scott Requadt is currently the Director at Variation Biotechnologies (US), Inc., the Independent Director at ESSA Pharma, Inc., and the Legal Advisor at Phoenix Strategy Investments LLC.
Previously, he served as the President, Chief Executive Officer & Director at Talaris Therapeutics, Inc. from 2018 to 2023.
He has also held positions as a Director at Biolex Therapeutics, Inc., TYRX, Inc., Link Medicine Corp., Astria Therapeutics, Inc., Oxford Immunotec Global Ltd., TransForm Pharmaceuticals, Inc., Quest Diagnostics TB LLC, eDev SARL, VBI Vaccines, Inc., Avrobio, Inc., VBI Vaccines, Inc., Verband Beratender Ingenieure VBI, Clarus Lifesciences III LP, Clarus Ventures LLC, and Blackstone, Inc. Additionally, Mr. Requadt worked as an Attorney at Davis Polk & Wardwell LLP from 1995 to 1999.
He holds an undergraduate degree from McGill University, a graduate degree from the University of Toronto, and an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.40% | 2023-07-02 | 102,817 ( 0.40% ) | 2 M $ | 2024-04-29 |
ESSA PHARMA INC
0.07% | 2024-03-24 | 30,002 ( 0.07% ) | 183 612 $ | 2024-04-29 |
Scott Requadt active positions
| Companies | Position | Start |
|---|---|---|
| ESSA PHARMA INC. | Director/Board Member | 2016-01-13 |
Phoenix Strategy Investments LLC
 Phoenix Strategy Investments LLC Investment ManagersFinance Phoenix Strategy Investments LLC (Phoenix Strategy) is a private equity firm founded by Michael R. Zani and Daniel Muzquiz in 2002. The firm is headquartered in Dallas. | Consultant / Advisor | - |
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Director/Board Member | - |
Former positions of Scott Requadt
| Companies | Position | End |
|---|---|---|
| TOURMALINE BIO, INC. | Chief Executive Officer | 2023-05-25 |
| BLACKSTONE INC. | Corporate Officer/Principal | 2022-12-01 |
Clarus Lifesciences III LP
 Clarus Lifesciences III LP Investment ManagersFinance Clarus Lifesciences III LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of pharmaceutical, biotechnology and medical devices. It provides financing for seed, early and later stage capital requirements with an investment size of USD 15 - 50 million. | Corporate Officer/Principal | 2020-11-30 |
| VBI VACCINES INC. | Director/Board Member | 2019-03-30 |
| AVROBIO, INC. | Director/Board Member | 2018-11-30 |
Training of Scott Requadt
| McGill University | Undergraduate Degree |
| University of Toronto | Graduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| BLACKSTONE INC. | Finance |
| ESSA PHARMA INC. | Health Technology |
| AVROBIO, INC. | Health Technology |
| VBI VACCINES INC. | Health Technology |
| Private companies | 15 |
|---|---|
Biolex Therapeutics, Inc.
 Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Biolex Therapeutics, Inc. developed and produced drugs. The company was founded in 1997 and was headquartered in Pittsboro, NC. | Distribution Services |
TYRX, Inc.
 TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Electronic Technology |
Link Medicine Corp.
 Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Health Technology |
Oxford Immunotec Global Ltd.
 Oxford Immunotec Global Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Global Ltd. operates as a diagnostics company, which develops and commercializes proprietary tests for immunology and infectious disease. Its products include T-SPOT.TB, T-SPOT.CMV, T-SPOT.PRT and T-CELL XTEND. The company was founded by Peter James Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Clarus Lifesciences III LP
Clarus Lifesciences III LP Investment ManagersFinance Clarus Lifesciences III LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of pharmaceutical, biotechnology and medical devices. It provides financing for seed, early and later stage capital requirements with an investment size of USD 15 - 50 million. | Finance |
Davis Polk & Wardwell LLP
 Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Davis Polk & Wardwell LLP provides legal services. It offers legal solutions to areas such as capital markets, mergers and acquisitions, credit, insolvency, and restructuring, investment management, tax, and litigation. The company was founded by Francis N. Bangs in 1849 and is headquartered in New York, NY. | Commercial Services |
Phoenix Strategy Investments LLC
Phoenix Strategy Investments LLC Investment ManagersFinance Phoenix Strategy Investments LLC (Phoenix Strategy) is a private equity firm founded by Michael R. Zani and Daniel Muzquiz in 2002. The firm is headquartered in Dallas. | Finance |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Health Technology |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Quest Diagnostics TB LLC
 Quest Diagnostics TB LLC Medical SpecialtiesHealth Technology Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA. | Health Technology |
eDev SARL
 eDev SARL Financial ConglomeratesFinance eDev SARL develops approved drug service companies. The company is headquartered in Luxembourg. | Finance |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
Verband Beratender Ingenieure VBI
 Verband Beratender Ingenieure VBI Miscellaneous Commercial ServicesCommercial Services Verband Beratender Ingenieure VBI is a consulting and engineering association based in Germany. | Commercial Services |
VBI Vaccines, Inc. /Old/
 VBI Vaccines, Inc. /Old/ BiotechnologyHealth Technology VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Scott Requadt
